CD274 and bladder transitional cell carcinoma: For example, Powles T et al. 15 studied PD-L1 positivity in metastatic urothelial bladder cancer patients: the prevalence of positive PD-L1 expression in tumour-infiltrating immunocytes and tumour cells was 27% (55 patients) and 11% (22 patients), respectively.